Surrozen, Inc.
SRZN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001824893
In the last 90 days, Surrozen, Inc. insiders filed 0 open-market purchases and 1 sale; 70 institutions reported holding it in 13F filings for Q2 2026, worth $314.5M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Surrozen, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +29 vs. Q2 2021
- Shares held
- 21.5M
- +21.5M vs. Q2 2021
- Total value
- $150.7M
- +$150.7M vs. Q2 2021
- New holders
- 29
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $314.5M |
| Q1 2026 | 59 | $314.2M |
| Q4 2025 | 55 | $195.1M |
| Q3 2025 | 36 | $81.7M |
| Q2 2025 | 31 | $53.9M |
| Q1 2025 | 30 | $63.5M |
| Q4 2024 | 24 | $35.4M |
| Q3 2024 | 23 | $25.5M |
| Q2 2024 | 21 | $23.1M |
| Q1 2024 | 16 | $15.0M |
| Q4 2023 | 17 | $9.78M |
| Q3 2023 | 25 | $7.90M |
| Q2 2023 | 22 | $8.62M |
| Q1 2023 | 23 | $9.91M |
| Q4 2022 | 26 | $9.36M |
| Q3 2022 | 27 | $44.1M |
| Q2 2022 | 24 | $63.1M |
| Q1 2022 | 30 | $67.4M |
| Q4 2021 | 32 | $153.5M |
| Q3 2021 | 29 | $150.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Surrozen, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DuPont Capital Management Corp | 4 | $0 | 0.00% | +4 | New |
| Wells Fargo & Company | 133 | $1.00K | 0.00% | +133 | New |
| JPMorgan Chase & Co | 417 | $3.00K | 0.00% | +417 | New |
| Wolverine Asset Management LLC | 1,619 | $11.0K | 0.00% | +1,619 | New |
| Highbridge Capital Management LLC | 11,701 | $83.0K | 0.00% | +11,701 | New |
| Virtu Financial LLC | 22,462 | $159.0K | 0.01% | +22,462 | New |
| BlackRock Inc. | 34,959 | $248.0K | 0.00% | +34,959 | New |
| Northern Trust Corp | 37,988 | $269.0K | 0.00% | +37,988 | New |
| Jasper Ridge Partners, L.P. | 46,838 | $332.0K | 0.01% | +46,838 | New |
| State Street Corp | 67,300 | $476.0K | 0.00% | +67,300 | New |
| Prelude Capital Management, LLC | 73,843 | $523.0K | 0.03% | +73,843 | New |
| Geode Capital Management, LLC | 128,539 | $910.0K | 0.00% | +128,539 | New |
| Boxer Capital, LLC | 200,000 | $1.42M | 0.05% | +200,000 | New |
| Hudson Bay Capital Management LP | 300,000 | $2.11M | 0.03% | +300,000 | New |
| Samsara BioCapital, LLC | 300,000 | $2.12M | 0.35% | +300,000 | New |
| Laurion Capital Management LP | 370,000 | $2.62M | 0.04% | +370,000 | New |
| Alyeska Investment Group, L.P. | 500,000 | $2.96M | 0.04% | +500,000 | New |
| Perceptive Advisors LLC | 500,000 | $3.54M | 0.05% | +500,000 | New |
| Monashee Investment Management LLC | 500,000 | $3.54M | 0.66% | +500,000 | New |
| Bridger Management, LLC | 700,001 | $4.19M | 0.49% | +700,001 | New |
| Vanguard Group Inc | 621,238 | $4.40M | 0.00% | +621,238 | New |
| Trustees of Columbia University in the City of New York | 718,950 | $5.09M | 7.78% | +718,950 | New |
| Euclidean Capital LLC | 802,965 | $5.68M | 2.76% | +802,965 | New |
| Board of Trustees of The Leland Stanford Junior University | 806,374 | $5.71M | 0.43% | +806,374 | New |
| Harvard Management Co Inc | 826,852 | $5.85M | 0.34% | +826,852 | New |
| Consonance Capital Management LP | 1,000,000 | $6.72M | 3.68% | +1,000,000 | New |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 1,200,000 | $8.50M | 0.11% | +1,200,000 | New |
| Baker Bros. Advisors LP | 2,500,000 | $17.7M | 0.08% | +2,500,000 | New |
| The Column Group LLC | 9,248,129 | $65.5M | 7.45% | +9,248,129 | New |